Insulet (NASDAQ:PODD) Now Covered by Analysts at SVB Leerink
SVB Leerink assumed coverage on shares of Insulet (NASDAQ:PODD – Free Report) in a report released on Monday, Benzinga reports. The firm issued an outperform rating and a $184.00 price objective on the medical instruments supplier’s stock. PODD has been the topic of several other research reports. Raymond James cut their target price on Insulet […]